Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the comparative detection of nucleocapsid protein from SARS-CoV-2 in NP swab specimens. Samples are to be collected within 7 days of symptom onset by professional healthcare providers in response to individuals reporting suspected symptoms of COVID-19.
